Mitochondria-Enriched Cell Identification, EP4281579A1

EPO published patent application EP4281579A1 for Minovia Therapeutics Ltd., covering methods of identifying mitochondria-enriched cells through C12Q and C12N classification techniques. The application was filed with IPC classifications including C12Q 1/26, C12Q 1/32, G01N 33/50, and C12N 5/073.

Affected parties include Minovia Therapeutics as the applicant/patent holder and any entities operating in cell therapy or cellular medicine development who may need to license this technology or design around the claims once the patent proceeds to grant. The patent provides enforceable IP rights across 39 designated states.